| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 |
| filingDate |
1986-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1987-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa59e528a1a8378c522eaf23a5c96186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2b6c8ccd48c93ef61e9a648146517e6 |
| publicationDate |
1987-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4698347-A |
| titleOfInvention |
Octahydro-oxazolo[4,5-g]quinolines derivatives and decahydro quinoline intermediates and their use as dopamine D-2 agonists |
| abstract |
Trans-(+/-)-2- and/or -5-permissibly substituted octahydro-oxazolo[4,5-g]quinolines, acid addition salts thereof and individual enantiomers thereof, useful as dopamine agonists or intermediates of the preparation of dopamine agonists. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6103777-A |
| priorityDate |
1985-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |